Biotech companies, whether they are establishing their legacy or just entering the field, are on the brink of major achievements in scientific innovation and mission-driven work.
Yet, amidst rapid growth and change, they often neglect to actively cultivate this mission through culture, communication, and engaging experiences like events and learning opportunities. Many businesses choose to address these “corporate” priorities at a later stage, a choice that can increase the risk of stumbling during the critical transition from start-up to established player.
Without a clearly defined and consistently applied mission, companies may find themselves years down the line with a lack of direction and cohesion, driven only by scientific ambitions and inconsistent behaviors.
So, how do you get this right? Hear from Allen Putman, Senior Communications and Engagement Consultant, Forty1 North America and Dean McAlister, EVP, Inizio, as they discuss how to build and balance a high culture to maximize your organizational potential here.
Jump to a slide with the slide dots.
Congress engagement is being redefined - driven by oncologists’ learning preferences, AI integration, sustainability mandates, and smart booth design.
Read moreFrom LED walls to real-time in-booth optimization, ASCO® 2025 uncovered how we should engage and evolve the congress experience.
Read moreIt’s been a few weeks since ASCO® 2025, but one moment from the podium still echoes in my mind - the possibility of curing metastatic cancer.
Read more